Corden Pharma Brussels SA
Dissolution volontaire – liquidation 51.5 FTECorden Pharma Brussels reported revenue of €3.28m for the 2024 financial year (annual accounts filed with the NBB on 24 Sep 2025), with 51.5 full-time equivalents.
The score of Corden Pharma Brussels shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Revenue -87 % Total assets -93 % Headcount (avg FTE) -31 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Corden Pharma Brussels's annual accounts
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Revenue | €3.28m | ||||
| Net result | −€11.8m | ||||
| Equity | −€38.1m | ||||
| Cash | 760,740 € | ||||
| EBITDA | −€17.5m | ||||
| Total assets | €1.22m |
Filed annual accounts
- Year ended 31 Dec 2024filed on 24 Sep 2025
- Year ended 31 Dec 2023filed on 30 Oct 2024
- Year ended 31 Dec 2022filed on 27 Jul 2023
- Year ended 31 Dec 2021filed on 28 Jun 2022
- Year ended 31 Dec 2020filed on 21 Jun 2021
Corden Pharma Brussels's financial analysis
- Solvency-3112.3%sector median: 24.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Corden Pharma Brussels
Corden Pharma Brussels's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0430.891.915
- VAT number
- BE0430891915
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 09 Apr 1987
- Registered office
- 1050 Ixelles
- Size
- Medium · 51.5 FTE
- Latest accounts
- 2024 · filed on 24 Sep 2025
- Activity
- Manufacture of other organic basic chemicals (NACE 20140)
Corden Pharma Brussels (SA) has been based in Ixelles since 1987, active in: manufacture of other organic basic chemicals. For 2024, it reports revenue of €3.28m, a net loss of €11.8m and equity of −€38.1m. With 51.5 full-time equivalents, it is a medium-sized enterprise by headcount. Its solvency stands at -3112.3%, below the median of its sector (24.8%).
Guide: Checking a Belgian supplier invoice: numbers and IBAN →
Companies similar to Corden Pharma Brussels
Companies in the same business, of comparable size and area, outside its group.
- Kemira Waterchemie NV Manufacture of other organic basic chemicals Aartselaar · balance sheet €1.63m
- Famenne Enrobes Manufacture of other organic basic chemicals Marche-en-Famenne · balance sheet €6.72m
- Keminal Manufacture of basic pharmaceutical products Ghent · balance sheet €2.00m
- Ensagent Manufacture of other organic basic chemicals Ghent · balance sheet €5.05m
- Additex Manufacture of other inorganic basic chemicals Mouscron · balance sheet €4.61m
- Sluys International Manufacture of other organic basic chemicals Duffel · balance sheet €4.86m
- PLIXXENT Belgium Manufacture of other organic basic chemicals Ghent · balance sheet €2.50m
- Arkema Antwerp Manufacture of other organic basic chemicals Brussels · balance sheet €13.2m
Frequently asked questions about Corden Pharma Brussels
What is the revenue of Corden Pharma Brussels?
According to the 2024 annual accounts filed with the NBB, the revenue of Corden Pharma Brussels amounts to 3,282,025 €.
What is the VAT number of Corden Pharma Brussels?
In Belgium, the VAT number is the company number prefixed with BE: BE0430891915 for Corden Pharma Brussels, if the company is VAT-registered. Its company number (CBE) is 0430.891.915.
Where is the registered office of Corden Pharma Brussels?
According to the CBE register, the registered office of Corden Pharma Brussels is in 1050 Ixelles.
What is the equity of Corden Pharma Brussels?
At the close of the 2024 financial year, the equity of Corden Pharma Brussels amounts to -38,057,573 €, a solvency of -3112.3% of total assets.
How many people work at Corden Pharma Brussels?
51.5 full-time equivalents on average according to the 2024 social balance sheet.
Who manages Corden Pharma Brussels?
The register lists 1 active mandates at Corden Pharma Brussels. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Corden Pharma Brussels
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →